Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation-Reference-Cited by-同舟云学术

Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation

Published:2015-02-11 Issue:5 Volume:65 Page:777-787
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Matsukawa Toshihiro,Izawa Kumi,Isobe Masamichi,Takahashi Mariko,Maehara Akie,Yamanishi Yoshinori,Kaitani Ayako,Okumura Ko,Teshima Takanori,Kitamura Toshio,Kitaura Jiro

Publisher

BMJ

Subject

Gastroenterology

Reference26 articles.

1. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation;Cader;Gut,2013

2. Inflammatory bowel disease;Kaser;Annu Rev Immunol,2010

3. Innate immune mechanisms of colitis and colitis-associated colorectal cancer;Saleh;Nat Rev Immunol,2011

4. The role of pattern recognition receptors in intestinal inflammation;Fukata;Mucosal Immunol,2013

5. Chemically induced mouse models of intestinal inflammation;Wirtz;Nat Protoc,2007

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD300f immune receptor is a microglial tissue damage sensor and regulates efferocytosis after brain damage;2024-09-10

2. Intranasal administration of ceramide liposome suppresses allergic rhinitis by targeting CD300f in murine models;Scientific Reports;2024-04-10

3. Sedanolide alleviates DSS-induced colitis by modulating the intestinal FXR-SMPD3 pathway in mice;Journal of Advanced Research;2024-04

4. The role of P2Y6 receptor in the pathogenesis of cardiovascular and inflammatory diseases;Journal of Pharmacological Sciences;2024-02

5. Dehydroandrographolide alleviates rheumatoid arthritis by inhibiting neutrophil activation via LMIR3 in collagen induced arthritis rats;Cell Cycle;2024-01-02